Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
detroit blog main
detroit top stories
27
×
national blog main
startups
27
×
national top stories
san francisco blog main
new york blog main
raleigh-durham blog main
san francisco top stories
seattle blog main
wisconsin blog main
biotech
boston blog main
life sciences
new york top stories
raleigh-durham top stories
san diego blog main
san diego top stories
seattle top stories
texas blog main
texas top stories
wisconsin top stories
boston top stories
national
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
deals
cancer
fda
cancer immunotherapy
clinical trials
alzheimer's disease
eli lilly
investing
novartis
pfizer
entrepreneurship
innovation
What
roundup
bio
drug
startup
companies
based
biotech
cancer
fda
new
technology
week
acquisitions
alzheimer’s
ann
announced
arbor
attention
ceo
develop
digital
drugs
life
medical
nash
news
pfizer’s
pharmaceutical
sciences
tech
today
ahead
amid
annual
approval
asco
biggest
black
bombast
buy
Language
unset
unknown
Current search:
startups
×
" detroit top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Healthtech Startups: Connect with HHS Officials in Detroit on July 15
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
4 years ago
HAP Partners With Livongo on Tech-Enabled Diabetes Compliance Program
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
MedHealth Summit Brings Together Cross-Border Innovators and Experts
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Celsee Charts Expansion Plans as Single-Cell Analysis Demand Grows
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@xconomy.com
6 years ago
Fictiv Raises $15M To Connect Tech Innovators & Parts Manufacturers